The assay uses genetic insights to identify patients with dihydropyrimidine dehydrogenase deficiency
The solution is designed to supercharge AI-driven high-throughput screening pipelines for antibody drug discovery
AndzonBio2, the ALBORADA Drug Discovery Institute at the University of Cambridge and Cambridge Enterprise are collaborating
Bringing together Ottimo Pharma and Lotte Biologics to advance Ottimo Pharma’s biparatopic antibody
The trial aims to halt fibrosis in those with diffuse cutaneous Systemic Sclerosis
Sign in to your account